PT  - JOURNAL ARTICLE
AU  - Bekliz, Meriem
AU  - Adea, Kenneth
AU  - Essaidi-Laziosi, Manel
AU  - Sacks, Jilian A
AU  - Escadafal, Camille
AU  - Kaiser, Laurent
AU  - Eckerle, Isabella
TI  - Analytical comparison of nine SARS-CoV-2 antigen-detecting rapid diagnostic tests for emerging SARS-CoV-2 variants
AID  - 10.1101/2021.05.31.21258111
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.31.21258111
4099  - http://medrxiv.org/content/early/2021/06/03/2021.05.31.21258111.short
4100  - http://medrxiv.org/content/early/2021/06/03/2021.05.31.21258111.full
AB  - Several SARS-CoV-2 variants of concern/interest (VOC/VOI) emerged recently, with VOCs outcompeting earlier lineages on a global scale. To date, few data on routine diagnostic performance for VOC/VOIs are available. Here, we investigate the analytical performance of nine commercially available antigen-detecting rapid diagnostic tests (Ag-RDTs) for VOC B.1.1.7, B.1.351, P.1 and VOI P.2 with cultured SARS-CoV-2. Comparable or higher sensitivity was observed for VOC/VOI compared to a non-VOC/VOI early-pandemic virus for all Ag-RDTs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swiss National Science Foundation (Grant Nr. 196383), the Fondation Ancrage Bienfaisance du Groupe Pictet, and the Foundation for Innovative New Diagnostics (FIND). The Swiss National Science Foundation and the Fondation Ancrage Bienfaisance du Groupe Pictet had no role in data collection, analysis, or interpretation. Ag-RDTs were provided by FIND and FIND was involved in methodology, data analysis, interpretation and writing.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:As a diagnostic validation study using cultured virus strains, no ethic approval is required as it does not involve patient data nor patient samples.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOriginal data are available upon request.